US Patent No: 8,101,205
Number of patents in Portfolio can not be more than 2000
Controlled release composition
Stats
-
Jan 24, 2012
Issued date -
Feb 21, 2008
filing date -
12/528,071
serial no -
In Force
status
Importance
Loading Importance Indicators...
Abstract
The invention relates to the field of pharmacology. More specific, the invention relates to a controlled release composition.) of the therapeutic protein is smaller than 2, preferably smaller than 1.5.
Loading the Abstract Image...
First Claim
Related Publications
Loading Related Publications...
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art
| Patent Info | (Count) | # Cites | Year |
|---|---|---|---|
|
|
|||
| 6,150,081 Silver halide emulsions with recombinant collagen suitable for photographic application and also the preparation thereof | 20 | 1998 | |
| 2007/0004,034 Process for coating cell-culture support | 8 | 2003 | |
| 7,517,954 RGD-enriched gelatine-like proteins with enhanced cell binding | 9 | 2004 | |
| 2006/0241,032 Rgd-enriched gelatine-like proteins with enhanced cell binding | 8 | 2004 | |
| 2006/0204,511 Use of recombinant or synthetic gelatin as stabiliser in vaccines | 5 | 2004 | |
| 2007/0031,501 Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions | 12 | 2004 | |
| 2008/0107,666 Non-Glycosylated Recombinant Collagen-Like Polypeptides | 7 | 2006 | |
| 2008/0113,910 RGD-ENRICHED GELATINE-LIKE PROTEINS WITH ENHANCED CELL BINDING | 8 | 2007 | |
| 2008/0114,078 RGD-ENRICHED GELATINE-LIKE PROTEINS WITH ENHANCED CELL BINDING | 8 | 2007 | |
| 2008/0167,446 RGD-ENRICHED GELATINE-LIKE PROTEINS WITH ENHANCED CELL BINDING | 8 | 2007 | |
| 2008/0274,957 RGD-ENRICHED GELATINE-LIKE PROTEINS WITH ENHANCED CELL BINDING | 8 | 2007 | |
|
|
|||
| 6,992,172 Recombinant gelatins | 35 | 2000 | |
| 2006/0147,501 Collagen compositions and biomaterials | 9 | 2004 | |
| 2005/0058,703 Gelatin capsules | 7 | 2004 | |
| 2009/0143,568 Recombinant gelatins | 7 | 2008 | |
|
|
|||
| 2002/0028,243 Protein matrix materials, devices and methods of making and using thereof | 73 | 2001 | |
| 2003/0007,991 Devices including protein matrix materials and methods of making and using thereof | 14 | 2001 | |
| 2002/0106,410 Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices | 8 | 2001 | |
| 2005/0147,690 Biocompatible protein particles, particle devices and methods thereof | 21 | 2004 | |
|
|
|||
| 5,023,082 Sustained-release pharmaceutical compositions | 72 | 1988 | |
| 5,002,769 Compositions for the sustained-release of chlorhexidine | 18 | 1989 | |
| 5,897,879 Sustained-release pharmaceutical system for the delivery of antioxidants | 12 | 1997 | |
|
|
|||
| 2004/0237,663 Delivery systems for functional ingredients | 14 | 2003 | |
| 2005/0208,141 Delivery systems for functional ingredients | 13 | 2005 | |
|
|
|||
| 5,399,361 Collagen-containing sponges as drug delivery compositions for proteins | 59 | 1994 | |
| 5,512,301 Collagen-containing sponges as drug delivery compositions for proteins | 24 | 1994 | |
|
|
|||
| 2006/0068,013 Non-adhesive elastic gelatin matrices | 13 | 2005 | |
| 2007/0009,580 Non-adhesive hydrogels | 7 | 2005 | |
|
|
|||
| 6,068,854 Sol-controlled thermocolloid matrix based on gelatin for oral sustained-release form | 11 | 1996 | |
|
|
|||
| 2006/0024,346 Stabilization of biologically active proteins with mixtures of polysaccharides and amino acid based compounds | 12 | 2004 | |
|
|
|||
| 6,458,386 Medicaments based on polymers composed of methacrylamide-modified gelatin | 22 | 2000 | |
|
|
|||
| 5,733,994 Biodegradable, water-resistant polymer material | 13 | 1996 | |
|
|
|||
| 6,342,250 Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices | 32 | 1998 | |
|
|
|||
| 2006/0177,492 Collagen gel and process of producing the same | 7 | 2005 | |
|
|
|||
| 2006/0024,361 Disintegrant assisted controlled release technology | 11 | 2004 | |
|
|
|||
| 6,831,058 Crosslinked gelatin gel preparation containing basic fibroblast growth factor | 11 | 1995 | |
|
|
|||
| 2006/0121,609 Gradient scaffolding and methods of producing the same | 12 | 2005 | |
|
|
|||
| 5,597,578 TGF-.beta. protein compositions for inhibition of cell proliferation | 36 | 1994 | |
|
|
|||
| 2006/0251,719 Sustained-release hydrogel preparation | 8 | 2004 | |
|
|
|||
| 6,140,072 Functional recombinantly prepared synthetic protein polymer | 30 | 1995 | |
|
|
|||
| 4,855,134 Sustained-release preparation | 26 | 1986 | |
|
|
|||
| 2003/0064,074 Recombinant gelatins in vaccines | 14 | 2002 | |
| 2005/0238,663 Recombinant stabilizer botulinum toxin pharmaceutical compositions | 11 | 2004 | |
| 2007/0190,153 Delivery systems for non-steroidal anti-inflammatory drugs (nsaids) | 8 | 2004 | |
| 2007/0196,496 Delivery systems for functional ingredients | 8 | 2006 | |
Patent Citation Ranking
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Jul 24, 2015 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Jul 24, 2019 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jul 24, 2023 |
| Fee | Large entity fee | small entity fee | micro entity fee |
|---|---|---|---|
| Surcharge - 3.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge - 7.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
| Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |